Total Payments
$1,138
2021 Payments
$20.30
Companies
22
Transactions
66
Payment Breakdown by Category
Food & Beverage$1,138 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,138 | 66 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $196.83 | 13 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $170.06 | 9 | $0 (2018) |
| Janssen Biotech, Inc. | $157.00 | 9 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $106.35 | 7 | $0 (2018) |
| Foundation Medicine, Inc. | $54.26 | 1 | $0 (2018) |
| Seattle Genetics, Inc. | $53.05 | 3 | $0 (2018) |
| PFIZER INC. | $52.82 | 3 | $0 (2021) |
| Regeneron Pharmaceuticals, Inc. | $44.00 | 1 | $0 (2018) |
| AbbVie, Inc. | $42.74 | 2 | $0 (2018) |
| Amgen Inc. | $33.63 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $20.30 | 1 | PFIZER INC. ($20.30) |
| 2018 | $468.05 | 26 | E.R. Squibb & Sons, L.L.C. ($92.40) |
| 2017 | $649.39 | 39 | Genentech USA, Inc. ($148.38) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2021 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Oncology | ||||||
| 11/03/2018 | Regeneron Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $44.00 | General |
| 08/24/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: Oncology | ||||||
| 08/17/2018 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Oncology | ||||||
| 08/02/2018 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: ONCOLOGY | ||||||
| 07/20/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Oncology | ||||||
| 07/18/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.67 | General |
| Category: Oncology | ||||||
| 07/11/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Oncology | ||||||
| 06/27/2018 | Genentech USA, Inc. | Perjeta (Biological) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: BioOncology | ||||||
| 06/26/2018 | MEDIVATION FIELD SOLUTIONS LLC | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Oncology | ||||||
| 05/24/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.49 | General |
| Category: Oncology | ||||||
| 05/23/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Oncology | ||||||
| 05/17/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Oncology | ||||||
| 04/25/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Oncology | ||||||
| 04/20/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Oncology | ||||||
| 03/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/16/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $54.26 | General |
| Category: ONCOLOGY | ||||||
| 03/14/2018 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Virology | ||||||
| 03/08/2018 | Novartis Pharmaceuticals Corporation | JADENU (Drug), PROMACTA | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: HEMATOLOGY | ||||||
| 03/05/2018 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Oncology | ||||||
| 03/02/2018 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $11.23 | General |
| Category: Oncology | ||||||
| 02/26/2018 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: BioOncology | ||||||
| 02/15/2018 | Novartis Pharmaceuticals Corporation | AFINITOR (Drug), SANDOSTATIN LAR | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: ONCOLOGY | ||||||
About Dr. Adriana Medina, M.D
Dr. Adriana Medina, M.D is a Hematology & Oncology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1316104136.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adriana Medina, M.D has received a total of $1,138 in payments from pharmaceutical and medical device companies, with $20.30 received in 2021. These payments were reported across 66 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,138).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Washington, DC
- Active Since 05/20/2008
- Last Updated 05/20/2008
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1316104136
Products in Payments
- EMPLICITI (Biological) $92.55
- Perjeta (Biological) $81.56
- OPDIVO (Biological) $77.51
- TECENTRIQ (Biological) $72.10
- IMBRUVICA (Drug) $70.35
- DARZALEX (Biological) $68.86
- FOUNDATIONONE (Device) $54.26
- ADCETRIS (Biological) $53.05
- Venclexta (Drug) $42.74
- AFINITOR (Drug) $34.56
- JADENU (Drug) $33.98
- Avastin (Biological) $33.83
- Kyprolis (Biological) $33.63
- Cabometyx (Drug) $33.21
- TASIGNA (Drug) $24.62
- Abraxane (Drug) $24.22
- FASLODEX (Drug) $22.18
- TORISEL (Drug) $20.41
- IBRANCE (Drug) $20.30
- Ixempra (Drug) $18.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Washington
Imad Tabbara, M.d, M.D
Hematology & Oncology — Payments: $1.8M
Hematology & Oncology $1.8M
John Marshall
Hematology & Oncology — Payments: $770,250
Hematology & Oncology $770,250
Dr. Catherine Broome, Md, MD
Hematology & Oncology — Payments: $693,161
Hematology & Oncology $693,161
Craig Kessler
Hematology & Oncology — Payments: $632,186
Hematology & Oncology $632,186
Claudine Isaacs
Hematology & Oncology — Payments: $406,847
Hematology & Oncology $406,847
Muhammad Mirza, M.d, M.D
Hematology & Oncology — Payments: $118,419
Hematology & Oncology $118,419